a man receives treatment at a hepatitis C treatment program PennsylvaniaAccording to the Center for Disease Control, an estimated 2.4 million people in America have Hepatitis C. Typically, the virus develops slowly over decades, with no symptoms until serious damage is done. Without treatment, the virus can cause liver failure and liver cancer, often requiring a liver transplant or resulting in death. However, at Positive Pathways, we offer treatment for Hepatitis C to the Pittsburgh area. We administer Mavyret, an FDA-approved Hepatitis C medication, to treat and even cure chronic Hepatitis C.

Why Do You Need a Hepatitis C Treatment Center in Pennsylvania?

Some people might be more likely than others to contract Hepatitis C. According to the CDC, the following people are at the highest risk to contract the Hepatitis C virus:

  • Current or former injection drug users, even those who injected only once
  • Recipients of blood transfusions or solid organ transplants prior to July 1992, when blood donors started being tested more thoroughly
  • Recipients of clotting factor concentrates made before 1987 when less advanced methods for manufacturing those products were used
  • People who regularly receive hemodialysis
  • People with known exposure to HCV, like health care workers who work with HCV-positive patients
  • Recipients of blood or organs from a donor who tested HCV-positive
  • People with HIV infection
  • Children born to HCV-positive mothers

The Hepatitis C virus (HCV) causes inflammation of the liver that can lead to diminished liver function or liver failure. Additionally, some patients who suffer from chronic HCV infection over many years may have jaundice (yellowish eyes or skin). Other complications include bleeding, fluid accumulation in the abdomen, infections, liver cancer, and death. However, in recent years, new advancements in Hepatitis C treatment have led to better long-term outcomes through shorter treatments at a Hep C treatment center in Pennsylvania. A Hepatitis C treatment center in Pennsylvania can help you find the right treatment plan to recover.

Our Hepatitis C Treatment Program in Pennsylvania

Mavyret is an FDA-approved drug used to treat chronic Hepatitis C. Previously, Hepatitis C treatment required a year of grueling shots and pills that gave patients flu-like symptoms and still cured barely half of them. Starting late in 2013, Gilead Sciences revolutionized treatment with the first pill-only medicines that brought cures in 12 weeks for more than 90 percent of patients.

Mavyret is taken once daily with food for a minimum of 8 weeks. The FDA has approved Mavyret to treat all kinds of the Hepatitis C virus. In clinical trials, cure rates varied from 92% to 100%. Possible side effects of Mavyret include headache, fatigue, and nausea. You can also find out more about our Hepatitis C treatment program in Pennsylvania by contacting Positive Pathways today.

Contact Positive Pathways’ Outpatient Hep C Center in Pennsylvania

At Positive Pathways, we offer outpatient treatment for the following:

In our substance abuse treatment programs, we incorporate psychiatric counseling as well as medication. Additionally, through 12-step programs, we help our clients find support in the community. Our goal is to help our clients find meaningful, long-term recovery through our high-quality care.

In addition to our Hepatitis C Pennsylvania treatment program, we have a psychiatrist available multiple days a week. You’ll find everything you need in one location at our centers in Pittsburgh and Cranberry Township. Positive Pathways’ experienced staff is ready to help. Contact us today at 412.224.2812 to find out more about our Hepatitis C treatment program and more.